nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—AR—scrotum—sarcoma	0.0558	0.133	CbGeAlD
Fluoxymesterone—PRLR—mammary gland—sarcoma	0.0512	0.122	CbGeAlD
Fluoxymesterone—PRLR—myometrium—sarcoma	0.0363	0.0864	CbGeAlD
Fluoxymesterone—SHBG—hindlimb—sarcoma	0.0265	0.063	CbGeAlD
Fluoxymesterone—ESR1—periosteum—sarcoma	0.0262	0.0623	CbGeAlD
Fluoxymesterone—PRLR—uterus—sarcoma	0.0235	0.056	CbGeAlD
Fluoxymesterone—PRLR—testis—sarcoma	0.0171	0.0407	CbGeAlD
Fluoxymesterone—PRLR—liver—sarcoma	0.0161	0.0384	CbGeAlD
Fluoxymesterone—Azoospermia—Thiotepa—sarcoma	0.0134	0.123	CcSEcCtD
Fluoxymesterone—ESR1—mammary gland—sarcoma	0.00778	0.0185	CbGeAlD
Fluoxymesterone—Oligospermia—Epirubicin—sarcoma	0.00694	0.0635	CcSEcCtD
Fluoxymesterone—SHBG—hematopoietic system—sarcoma	0.00673	0.016	CbGeAlD
Fluoxymesterone—SHBG—connective tissue—sarcoma	0.00648	0.0154	CbGeAlD
Fluoxymesterone—Oligospermia—Doxorubicin—sarcoma	0.00642	0.0587	CcSEcCtD
Fluoxymesterone—AR—myometrium—sarcoma	0.00563	0.0134	CbGeAlD
Fluoxymesterone—ESR1—myometrium—sarcoma	0.00552	0.0131	CbGeAlD
Fluoxymesterone—Azoospermia—Epirubicin—sarcoma	0.0054	0.0494	CcSEcCtD
Fluoxymesterone—ESR1—embryo—sarcoma	0.00531	0.0126	CbGeAlD
Fluoxymesterone—SHBG—uterus—sarcoma	0.00508	0.0121	CbGeAlD
Fluoxymesterone—AR—seminal vesicle—sarcoma	0.00508	0.0121	CbGeAlD
Fluoxymesterone—Azoospermia—Doxorubicin—sarcoma	0.00499	0.0457	CcSEcCtD
Fluoxymesterone—AR—hematopoietic system—sarcoma	0.00483	0.0115	CbGeAlD
Fluoxymesterone—ESR1—hematopoietic system—sarcoma	0.00474	0.0113	CbGeAlD
Fluoxymesterone—AR—connective tissue—sarcoma	0.00465	0.0111	CbGeAlD
Fluoxymesterone—Coagulopathy—Dactinomycin—sarcoma	0.0046	0.0421	CcSEcCtD
Fluoxymesterone—ESR1—connective tissue—sarcoma	0.00457	0.0109	CbGeAlD
Fluoxymesterone—SHBG—bone marrow—sarcoma	0.00431	0.0103	CbGeAlD
Fluoxymesterone—AR—smooth muscle tissue—sarcoma	0.00425	0.0101	CbGeAlD
Fluoxymesterone—AR—skin of body—sarcoma	0.0042	0.01	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—sarcoma	0.00418	0.00994	CbGeAlD
Fluoxymesterone—Amenorrhoea—Thiotepa—sarcoma	0.00411	0.0376	CcSEcCtD
Fluoxymesterone—NR3C1—myometrium—sarcoma	0.00407	0.0097	CbGeAlD
Fluoxymesterone—NR3C1—embryo—sarcoma	0.00392	0.00933	CbGeAlD
Fluoxymesterone—SHBG—testis—sarcoma	0.00369	0.00878	CbGeAlD
Fluoxymesterone—NR3C1—seminal vesicle—sarcoma	0.00368	0.00876	CbGeAlD
Fluoxymesterone—AR—cardiac atrium—sarcoma	0.00367	0.00873	CbGeAlD
Fluoxymesterone—AR—uterus—sarcoma	0.00365	0.00868	CbGeAlD
Fluoxymesterone—ESR1—uterus—sarcoma	0.00358	0.00853	CbGeAlD
Fluoxymesterone—Amenorrhoea—Mitoxantrone—sarcoma	0.00355	0.0325	CcSEcCtD
Fluoxymesterone—NR3C1—hematopoietic system—sarcoma	0.0035	0.00833	CbGeAlD
Fluoxymesterone—SHBG—liver—sarcoma	0.00349	0.0083	CbGeAlD
Fluoxymesterone—AR—lymphoid tissue—sarcoma	0.0034	0.00809	CbGeAlD
Fluoxymesterone—NR3C1—connective tissue—sarcoma	0.00337	0.00802	CbGeAlD
Fluoxymesterone—ESR1—lymphoid tissue—sarcoma	0.00334	0.00795	CbGeAlD
Fluoxymesterone—AR—tendon—sarcoma	0.0032	0.00761	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—sarcoma	0.00308	0.00733	CbGeAlD
Fluoxymesterone—NR3C1—skin of body—sarcoma	0.00304	0.00724	CbGeAlD
Fluoxymesterone—NR3C1—cardiac atrium—sarcoma	0.00266	0.00632	CbGeAlD
Fluoxymesterone—AR—testis—sarcoma	0.00265	0.0063	CbGeAlD
Fluoxymesterone—NR3C1—uterus—sarcoma	0.00264	0.00629	CbGeAlD
Fluoxymesterone—ESR1—testis—sarcoma	0.0026	0.00619	CbGeAlD
Fluoxymesterone—AR—liver—sarcoma	0.0025	0.00596	CbGeAlD
Fluoxymesterone—NR3C1—lymphoid tissue—sarcoma	0.00246	0.00586	CbGeAlD
Fluoxymesterone—ESR1—liver—sarcoma	0.00246	0.00585	CbGeAlD
Fluoxymesterone—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00234	0.0214	CcSEcCtD
Fluoxymesterone—NR3C1—tendon—sarcoma	0.00232	0.00551	CbGeAlD
Fluoxymesterone—NR3C1—bone marrow—sarcoma	0.00224	0.00534	CbGeAlD
Fluoxymesterone—Seborrhoeic dermatitis—Epirubicin—sarcoma	0.00213	0.0195	CcSEcCtD
Fluoxymesterone—Seborrhoeic dermatitis—Doxorubicin—sarcoma	0.00197	0.0181	CcSEcCtD
Fluoxymesterone—Anaphylactoid reaction—Etoposide—sarcoma	0.00195	0.0178	CcSEcCtD
Fluoxymesterone—AR—lymph node—sarcoma	0.00192	0.00457	CbGeAlD
Fluoxymesterone—NR3C1—testis—sarcoma	0.00192	0.00456	CbGeAlD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.00189	0.00402	CbGpPWpGaD
Fluoxymesterone—ESR1—lymph node—sarcoma	0.00188	0.00448	CbGeAlD
Fluoxymesterone—PRLR—Signaling by ERBB4—KRAS—sarcoma	0.00186	0.00396	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Thiotepa—sarcoma	0.00182	0.0167	CcSEcCtD
Fluoxymesterone—Haemorrhage—Thiotepa—sarcoma	0.00181	0.0166	CcSEcCtD
Fluoxymesterone—NR3C1—liver—sarcoma	0.00181	0.00431	CbGeAlD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00181	0.00385	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—FOXO1—sarcoma	0.0018	0.00383	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—CREB1—sarcoma	0.0018	0.00383	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.00174	0.0037	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.00174	0.0037	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.00171	0.00363	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Epirubicin—sarcoma	0.00165	0.0151	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Epirubicin—sarcoma	0.00165	0.0151	CcSEcCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—JUN—sarcoma	0.00165	0.00351	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—MDM2—sarcoma	0.00164	0.00348	CbGpPWpGaD
Fluoxymesterone—Alopecia—Thiotepa—sarcoma	0.0016	0.0147	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.00159	0.00338	CbGpPWpGaD
Fluoxymesterone—Alopecia—Dactinomycin—sarcoma	0.00159	0.0146	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—HRAS—sarcoma	0.00159	0.00337	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL2—sarcoma	0.00158	0.00336	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.00158	0.00336	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Mitoxantrone—sarcoma	0.00157	0.0144	CcSEcCtD
Fluoxymesterone—Haemorrhage—Mitoxantrone—sarcoma	0.00157	0.0143	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Doxorubicin—sarcoma	0.00153	0.014	CcSEcCtD
Fluoxymesterone—Amenorrhoea—Doxorubicin—sarcoma	0.00153	0.014	CcSEcCtD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.00153	0.00324	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.0015	0.00318	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.00147	0.00313	CbGpPWpGaD
Fluoxymesterone—NR3C1—Circadian Clock—CREB1—sarcoma	0.00146	0.00309	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—JUN—sarcoma	0.00142	0.00302	CbGpPWpGaD
Fluoxymesterone—Alopecia—Vincristine—sarcoma	0.00142	0.013	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.00141	0.00299	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.0014	0.00297	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00139	0.00296	CbGpPWpGaD
Fluoxymesterone—NR3C1—lymph node—sarcoma	0.00139	0.00331	CbGeAlD
Fluoxymesterone—PRLR—Immune System—PTPRC—sarcoma	0.00139	0.00295	CbGpPWpGaD
Fluoxymesterone—Alopecia—Mitoxantrone—sarcoma	0.00138	0.0127	CcSEcCtD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—HRAS—sarcoma	0.00138	0.00293	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PLCG1—sarcoma	0.00136	0.00289	CbGpPWpGaD
Fluoxymesterone—Anxiety—Thiotepa—sarcoma	0.00134	0.0123	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—NRAS—sarcoma	0.00133	0.00282	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TLE1—sarcoma	0.00133	0.00282	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—sarcoma	0.00132	0.00281	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.00132	0.00281	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CREB1—sarcoma	0.00131	0.00278	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.0013	0.00277	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ATF1—sarcoma	0.00129	0.00274	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—SRC—sarcoma	0.00128	0.00271	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CCND1—sarcoma	0.00127	0.00271	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.00127	0.0027	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—sarcoma	0.00126	0.00268	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—MDM2—sarcoma	0.00124	0.00264	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.00122	0.00259	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.00122	0.00259	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.00121	0.00256	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CREB1—sarcoma	0.0012	0.00255	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.00118	0.00251	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00116	0.00247	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Thiotepa—sarcoma	0.00116	0.0106	CcSEcCtD
Fluoxymesterone—Anxiety—Mitoxantrone—sarcoma	0.00116	0.0106	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.00115	0.00245	CbGpPWpGaD
Fluoxymesterone—Alopecia—Etoposide—sarcoma	0.00115	0.0105	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—KRAS—sarcoma	0.00114	0.00243	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Vincristine—sarcoma	0.00114	0.0105	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFC—sarcoma	0.00112	0.00238	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00111	0.0102	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.0011	0.00234	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Epirubicin—sarcoma	0.00109	0.00998	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.00108	0.00231	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—MDM2—sarcoma	0.00108	0.0023	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—JUN—sarcoma	0.00108	0.00229	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.00107	0.00228	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.00107	0.00227	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.00106	0.00225	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.00106	0.00225	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	0.00106	0.00225	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MYC—sarcoma	0.00104	0.00221	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Vincristine—sarcoma	0.00103	0.00939	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	0.00102	0.00218	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	0.00102	0.00217	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	0.00101	0.00216	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.00101	0.00215	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00101	0.00923	CcSEcCtD
Fluoxymesterone—NR3C1—Adipogenesis—FOXO1—sarcoma	0.00101	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.00101	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.00101	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.00101	0.00214	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Mitoxantrone—sarcoma	0.000999	0.00914	CcSEcCtD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000999	0.00212	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000986	0.0021	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HRAS—sarcoma	0.000972	0.00207	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SRC—sarcoma	0.000968	0.00206	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FOXO1—sarcoma	0.000964	0.00205	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000964	0.00205	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PDGFRB—sarcoma	0.000963	0.00205	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.00096	0.00204	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Thiotepa—sarcoma	0.000949	0.00868	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—PDGFRA—sarcoma	0.000948	0.00201	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000944	0.00201	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Dactinomycin—sarcoma	0.000942	0.00862	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000942	0.002	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CCND1—sarcoma	0.000941	0.002	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—JUN—sarcoma	0.000939	0.002	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CTNNB1—sarcoma	0.000932	0.00198	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Etoposide—sarcoma	0.000925	0.00847	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000922	0.00196	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000911	0.00194	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000909	0.00193	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000904	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000902	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000901	0.00192	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000899	0.00191	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000897	0.00191	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FLT1—sarcoma	0.000894	0.0019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000888	0.00189	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL2—sarcoma	0.000888	0.00189	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLCG1—sarcoma	0.000879	0.00187	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000879	0.00187	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—CTNNB1—sarcoma	0.000877	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000877	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.000875	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.00087	0.00185	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CCND1—sarcoma	0.000865	0.00184	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—JUN—sarcoma	0.000863	0.00183	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000857	0.00182	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000856	0.00182	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—sarcoma	0.000855	0.00182	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000849	0.0018	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCR4—sarcoma	0.000844	0.00179	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SRC—sarcoma	0.000842	0.00179	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Vincristine—sarcoma	0.000842	0.0077	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—ATF1—sarcoma	0.000835	0.00177	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000834	0.00177	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000831	0.00177	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Etoposide—sarcoma	0.000831	0.0076	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000822	0.00175	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Mitoxantrone—sarcoma	0.00082	0.0075	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000814	0.00173	CbGpPWpGaD
Fluoxymesterone—Headache—Thiotepa—sarcoma	0.000807	0.00738	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.000782	0.00166	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.00078	0.00166	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000774	0.00165	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000768	0.00163	CbGpPWpGaD
Fluoxymesterone—Nausea—Thiotepa—sarcoma	0.000765	0.007	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.000761	0.00162	CbGpPWpGaD
Fluoxymesterone—Nausea—Dactinomycin—sarcoma	0.000759	0.00695	CcSEcCtD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000757	0.00161	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—FUS—sarcoma	0.000754	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000744	0.00158	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.00074	0.00157	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—sarcoma	0.000738	0.00157	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KIT—sarcoma	0.000735	0.00156	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Epirubicin—sarcoma	0.000734	0.00671	CcSEcCtD
Fluoxymesterone—NR3C1—Adipogenesis—CREB1—sarcoma	0.000732	0.00155	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Epirubicin—sarcoma	0.00073	0.00668	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000721	0.00153	CbGpPWpGaD
Fluoxymesterone—Headache—Vincristine—sarcoma	0.000716	0.00655	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000709	0.00151	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000708	0.0015	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000705	0.0015	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000705	0.0015	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CREB1—sarcoma	0.000699	0.00149	CbGpPWpGaD
Fluoxymesterone—Headache—Mitoxantrone—sarcoma	0.000697	0.00638	CcSEcCtD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MYC—sarcoma	0.000694	0.00147	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000689	0.00146	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Etoposide—sarcoma	0.000682	0.00624	CcSEcCtD
Fluoxymesterone—Haemoglobin—Doxorubicin—sarcoma	0.000679	0.00621	CcSEcCtD
Fluoxymesterone—Nausea—Vincristine—sarcoma	0.000679	0.00621	CcSEcCtD
Fluoxymesterone—Haemorrhage—Doxorubicin—sarcoma	0.000676	0.00618	CcSEcCtD
Fluoxymesterone—Nausea—Mitoxantrone—sarcoma	0.000661	0.00605	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000659	0.0014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000656	0.00139	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—sarcoma	0.000655	0.00139	CbGpPWpGaD
Fluoxymesterone—Alopecia—Epirubicin—sarcoma	0.000645	0.0059	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000632	0.00134	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000627	0.00133	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FOXO1—sarcoma	0.000624	0.00133	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDGFRB—sarcoma	0.000622	0.00132	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000618	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000617	0.00131	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000615	0.00131	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDGFRA—sarcoma	0.000613	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000611	0.0013	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—JUN—sarcoma	0.000599	0.00127	CbGpPWpGaD
Fluoxymesterone—Alopecia—Doxorubicin—sarcoma	0.000597	0.00546	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000595	0.00126	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000587	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—FUS—sarcoma	0.000581	0.00123	CbGpPWpGaD
Fluoxymesterone—Headache—Etoposide—sarcoma	0.00058	0.0053	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—MDM2—sarcoma	0.000579	0.00123	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000579	0.00123	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—FUS—sarcoma	0.000572	0.00122	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—sarcoma	0.00057	0.00121	CbGpPWpGaD
Fluoxymesterone—Nausea—Etoposide—sarcoma	0.00055	0.00503	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000546	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000545	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000542	0.00115	CbGpPWpGaD
Fluoxymesterone—Anxiety—Epirubicin—sarcoma	0.000539	0.00493	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000538	0.00114	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.000524	0.00111	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000524	0.00111	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—sarcoma	0.000522	0.00111	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Epirubicin—sarcoma	0.000519	0.00475	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—IL2—sarcoma	0.000517	0.0011	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KDR—sarcoma	0.000516	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000511	0.00109	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.00051	0.00108	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000506	0.00108	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—JUN—sarcoma	0.000503	0.00107	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	0.000502	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—sarcoma	0.000499	0.00106	CbGpPWpGaD
Fluoxymesterone—Anxiety—Doxorubicin—sarcoma	0.000499	0.00456	CcSEcCtD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000495	0.00105	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000484	0.00103	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Doxorubicin—sarcoma	0.00048	0.00439	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—KIT—sarcoma	0.000475	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000475	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000474	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.00047	0.001	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Epirubicin—sarcoma	0.000466	0.00426	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000457	0.000972	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000457	0.000971	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000455	0.000966	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CREB1—sarcoma	0.000452	0.000961	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000452	0.00096	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000451	0.000959	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—SRC—sarcoma	0.000451	0.000959	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000445	0.000947	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NRAS—sarcoma	0.000434	0.000923	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Doxorubicin—sarcoma	0.000431	0.00394	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000414	0.00088	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.00041	0.000871	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000407	0.000865	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000406	0.000863	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000401	0.000852	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000397	0.000844	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—sarcoma	0.000395	0.000841	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000394	0.000836	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000393	0.000835	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.00039	0.000828	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Epirubicin—sarcoma	0.000382	0.0035	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000381	0.00081	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000379	0.000805	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MDM2—sarcoma	0.000374	0.000795	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—KRAS—sarcoma	0.000374	0.000794	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000373	0.000792	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000371	0.000788	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Doxorubicin—sarcoma	0.000354	0.00324	CcSEcCtD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000352	0.000749	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000352	0.000748	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.00035	0.000744	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000343	0.000729	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000337	0.000715	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL2—sarcoma	0.000334	0.000711	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCND1—sarcoma	0.000326	0.000693	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—JUN—sarcoma	0.000325	0.000691	CbGpPWpGaD
Fluoxymesterone—Headache—Epirubicin—sarcoma	0.000325	0.00297	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—sarcoma	0.000323	0.000686	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HRAS—sarcoma	0.000318	0.000675	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000316	0.000671	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000313	0.000665	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000309	0.000656	CbGpPWpGaD
Fluoxymesterone—Nausea—Epirubicin—sarcoma	0.000308	0.00282	CcSEcCtD
Fluoxymesterone—Headache—Doxorubicin—sarcoma	0.000301	0.00275	CcSEcCtD
Fluoxymesterone—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000298	0.000633	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SRC—sarcoma	0.000292	0.00062	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000292	0.00062	CbGpPWpGaD
Fluoxymesterone—Nausea—Doxorubicin—sarcoma	0.000285	0.00261	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—sarcoma	0.000284	0.000604	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NRAS—sarcoma	0.000281	0.000596	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MYC—sarcoma	0.000261	0.000556	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000259	0.000551	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—sarcoma	0.000256	0.000543	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TLE1—sarcoma	0.000249	0.000529	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KRAS—sarcoma	0.000242	0.000513	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—sarcoma	0.000215	0.000456	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFC—sarcoma	0.00021	0.000446	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HRAS—sarcoma	0.000205	0.000436	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—MYC—sarcoma	0.000204	0.000433	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FLT1—sarcoma	0.000168	0.000357	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLCG1—sarcoma	0.000165	0.000351	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR4—sarcoma	0.000159	0.000337	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—MYC—sarcoma	0.000157	0.000333	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ATF1—sarcoma	0.000157	0.000333	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—MYC—sarcoma	0.000154	0.000328	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—sarcoma	0.000123	0.000261	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FOXO1—sarcoma	0.000117	0.000249	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRB—sarcoma	0.000117	0.000248	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFRA—sarcoma	0.000115	0.000245	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MYC—sarcoma	9.8e-05	0.000208	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KDR—sarcoma	9.68e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KIT—sarcoma	8.92e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CREB1—sarcoma	8.49e-05	0.00018	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MYC—sarcoma	7.55e-05	0.00016	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MYC—sarcoma	7.44e-05	0.000158	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MDM2—sarcoma	7.03e-05	0.000149	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL2—sarcoma	6.28e-05	0.000133	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCND1—sarcoma	6.12e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—JUN—sarcoma	6.11e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—sarcoma	6.06e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SRC—sarcoma	5.48e-05	0.000116	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—sarcoma	5.34e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NRAS—sarcoma	5.27e-05	0.000112	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MYC—sarcoma	4.91e-05	0.000104	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—sarcoma	4.8e-05	0.000102	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KRAS—sarcoma	4.54e-05	9.64e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—sarcoma	4.03e-05	8.57e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRAS—sarcoma	3.86e-05	8.19e-05	CbGpPWpGaD
